0 NASDAQ Companies - September 4, 2019BioXcel Therapeutics Receives FDA Orphan Drug Designation for BXCL701 for the Treatment of Acute Myeloid Leukemia (AML)Read More
0 NASDAQ Companies - September 4, 2019Krystal Biotech Announces Initiation of Phase 1/2 Study of KB105 in Transglutaminase-1 (“TGM1”) Deficient Autosomal Recessive Congenital Ichthyosis (“ARCI”)Read More
0 NASDAQ Companies - September 4, 2019Selecta Biosciences Appoints Brad Dahms as Chief Financial OfficerRead More
0 NASDAQ Companies - September 4, 2019Vericel to Present at the 17th Annual Morgan Stanley Global Healthcare Conference on Wednesday, September 11, 2019Read More
0 NASDAQ Companies - September 4, 2019Centrexion Therapeutics Announces CNTX-4975, CNTX-0290 and CNTX-6970 Data Presentations at PAINWeek 2019 National ConferenceRead More
0 NASDAQ Companies - September 4, 2019Cellectar Announces Late-Breaker Poster Presentation at the 17th International Myeloma WorkshopRead More
0 NASDAQ Companies - September 4, 2019Nuance Board of Directors Declares Spin-Off Dividend of Cerence SharesRead More
0 NASDAQ Companies - September 4, 2019Sunrun To Help Power Hawaii With Rooftop Solar and Battery NetworkRead More
0 NASDAQ Companies - September 4, 2019Neustar to Move Sterling Headquarters to Comstock’s Second Iconic Office Tower in Reston Station Read More
0 NASDAQ Companies - September 4, 2019Chembio Diagnostics Announces $20 Million Term Loan with Perceptive AdvisorsRead More
